UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 23, 2010
AQUAMER MEDICAL CORP.
(Exact name of registrant as specified in its charter)
Delaware | | 000-52327 | | 04-3516924 |
| |
| |
|
(State or other jurisdiction
of incorporation) | | (Commission File Number) | | (IRS Employer
Identification No.) |
| | | | | | | |
360 Merrimack St., Bldg 5
Lawrence, MA | | 01843 |
| |
|
(Address of principal executive offices) | | (Zip Code) |
Registrant's telephone number, including area code: 781-389-9703
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers
On February 23, 2010, Marshall Sterman, the sole member of our Board of Directors, pursuant to our corporate bylaws, increased the size of the Board to two members and elected Richard Falcone as a new director.
The Board then approved the appointment of Mr. Falcone as President, Chief Executive Officer and Acting Chief Financial Officer, replacing Mr. Sterman in those positions. Mr. Sterman is continuing in his position as Chairman of the Board.
Mr. Falcone, a certified public accountant, is an experienced financial and operational executive in manufacturing, retail and technology companies. He was formerly CFO of Bed, Bath & Beyond Inc. and Director of International Finance and Operations for Tiffany & Co. During the past five years, Mr. Falcone, who has significant corporate turnaround experience, had served as President and CEO of Tasker Products Corp. and CFO of The A Consulting Team, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: | | 02/26/2010 |
| | | |
| | | Aquamer Medical Corp. |
| | |
|
| | | Registrant |
| | | |
By: | | /s/ Marshall Sterman |
| | |
|
| | | Marshall Sterman
Chairman of the Board |
